VOLITIONRX LTD Income Statement
VNRX|10 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
VOLITIONRX LTD reported $1M in revenue and $27M in net loss for FY2025. Revenue has grown at a 27.0% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M | $775.3K | $306.4K | $90.0K | $13.4K | $17.1K | $17.1K | $14.8K | $55.0K | $55.0K |
| SG&A Expense | $8.5M | $10.4M | $10.2M | $11.7M | $5.7M | $4.7M | $5.8M | $434.0K | $448.0K | $247.4K |
| R&D Expense | $14.4M | $19.6M | $15.3M | $13.0M | $14.5M | $10.4M | $10.9M | $2.5M | $2.8M | $1.5M |
| Operating Income | -$27.0M | -$36.0M | -$31.8M | -$28.3M | -$21.2M | -$16.0M | -$17.9M | -$4.6M | -$4.1M | -$2.6M |
| Interest Expense | - | - | - | - | $129.8K | $126.6K | -$110.9K | - | - | - |
| Net Income | -$27.0M | -$35.7M | -$30.6M | -$27.0M | -$20.4M | -$16.1M | -$18.0M | -$3.7M | -$3.5M | -$3.5M |
| EPS (Diluted) | - | -$0.50 | - | - | -$0.45 | -$0.41 | -$0.57 | -$0.34 | -$0.44 | -$0.45 |
| Shares Outstanding | 96.1M | 81.9M | 57.9M | 53.8M | 48.6M | 41.1M | 35.3M | 11.7M | 10.2M | 8.6M |
| Operating Margin | -2190.9% | -4641.8% | -10372.4% | -31469.0% | -158176.3% | -93840.2% | -104689.4% | -30949.7% | -7428.1% | -4745.4% |
| Profit Margin | -2186.3% | -4601.7% | -9986.7% | -29977.0% | -151859.5% | -94168.6% | -105338.2% | -25095.0% | -6372.0% | -6372.0% |